◀ Back to CTR9
CTR9 — PVR
Text-mined interactions from Literome
Bellan et al., Am J Physiol 1992
:
Pulmonary vascular resistance (PVR) was increased, systemic vascular resistance ( SVR ) was reduced, and changes in
PVR and SVR in
response to
PAF were blocked by the novel PAF receptor antagonist, BN 50730
Oral et al., J Cardiovasc Electrophysiol 2004
(Atrial Fibrillation...) :
PV isolation has a lower efficacy in patients with vagotonic PAF than in patients with adrenergic or random episodes of PAF, suggesting that the
PVs less often
play an important role in vagotonic
PAF
McCormack et al., Crit Care Med 1990
(Anoxia...) :
Additionally, indomethacin ( 2 mg/kg followed by 2 mg/kg.h iv ) treatment of the animals attenuated the
PAF induced increase in
PVR
Sánchez Crespo et al., Agents Actions 1981
:
Therefore, an experimental approach using 57Co and 113Sn radiolabelled microspheres was developed to evaluate the
effect of
PAF on cardiac output ( CO ),
peripheral vascular resistance (PVR) and redistribution of CO among organs